Needham Initiates Coverage On Veradermics with Buy Rating, Announces Price Target of $136

Benzinga Newsdesk www.benzinga.com Neutral 70.4%

Neg 0% Neu 70.4% Pos 0%

Needham analyst Serge Belanger initiates coverage on Veradermics (NYSE:MANE) with a Buy rating and announces Price Target of $136.